| ID Source | ID |
|---|---|
| PubMed CID | 21686 |
| CHEMBL ID | 2041315 |
| SCHEMBL ID | 176523 |
| MeSH ID | M0269110 |
| Synonym |
|---|
| HMS1786F09 |
| brn 2047887 |
| tricyclo(3.3.1.1(sup 3,7))decane-1-carboxamide |
| tricyclo[3.3.1.1~3,7~]decane-1-carboxamide |
| STL290663 |
| 1-adamantanecarboxamide |
| tricyclo(3.3.1.13,7)decane-1-carboxamide |
| EU-0066815 |
| OPREA1_331138 |
| 1-adamantanecarboxamide, 97% |
| 5511-18-2 |
| adamantane-1-carboxamide |
| perazine-d8 dihydrochloride salt |
| 9-minocycline-d6 disulfate salt |
| AKOS001023937 |
| adamantanecarboxamide |
| A830495 |
| adamantane-1-carboxylic acid amide |
| CHEMBL2041315 |
| GEO-02752 |
| FT-0621897 |
| AKOS017344467 |
| SCHEMBL176523 |
| admantane-1-carboxamide |
| CKBZJTAMRPPVSR-UHFFFAOYSA-N |
| 2,4-dinitrophenyltaurinesodiumsalt |
| W-200426 |
| DTXSID30203628 |
| sr-01000389674 |
| SR-01000389674-1 |
| mfcd00077200 |
| AS-58216 |
| 1246815-57-5 |
| Z56757306 |
| 1-adamantyl-carboxamide |
| BB 0266540 |
| 1316291-16-3 |
| CS-0149960 |
| 1-adamantane carboxamide |
| SY031536 |
| EN300-1718711 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID668903 | Inhibition of Influenza A Virus M2 proton channel expressed in Xenopus laevis oocytes at 100 uM after 2 mins by two-electrode patch clamp assay | 2011 | ACS medicinal chemistry letters, Apr-14, Volume: 2, Issue:4 | Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus. |
| AID668905 | Inhibition of Influenza A Virus M2 proton channel V27A mutant expressed in Xenopus laevis oocytes at 100 uM after 2 mins by two-electrode patch clamp assay | 2011 | ACS medicinal chemistry letters, Apr-14, Volume: 2, Issue:4 | Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus. |
| AID668906 | Inhibition of Influenza A Virus M2 proton channel S31N mutant expressed in Xenopus laevis oocytes at 100 uM after 2 mins by two-electrode patch clamp assay | 2011 | ACS medicinal chemistry letters, Apr-14, Volume: 2, Issue:4 | Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.87) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||